Matthias Alder is VP & Secretary at Sucampo Pharmaceuticals, Inc. (SCMP). They have made 4 open-market trades across 2 companies since 2010, most recently 2024-03-26.
CIK 0001365216
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GANX | SELL | 2023-12-21 | 2023-12-22 | $2.46 | $507 | +48.8% | +35.7% | +73.4% |
| GANX | SELL | 2023-12-07 | 2023-12-14 | $2.50 | $5K | +4.9% | +38.3% | +72.0% |
| SCMP | SELL | 2016-11-28 | 2016-11-28 | $16.73 | $418K | -7.0% | -17.4% | -25.1% |
| SCMP | SELL | 2016-11-23 | 2016-11-28 | $16.00 | $2.4M | -7.0% | -17.4% | -25.1% |
| MITI | SELL · 10b5-1 | 2010-01-25 | 2010-01-27 | $8.25 | $83K | N/A | N/A | N/A |
| MITI | SELL · 10b5-1 | 2010-01-19 | 2010-01-21 | $7.16 | $72K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.